Geoffrey Michael Glass - 10 Aug 2023 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Role
Director
Signature
/s/ Jerad G. Seurer, Attorney-in-Fact
Issuer symbol
AVDL
Transactions as of
10 Aug 2023
Net transactions value
+$187,600
Form type
4
Filing time
11 Aug 2023, 16:00:57 UTC
Previous filing
03 Aug 2023
Next filing
01 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVDL ADSs Purchase $187,600 +14,000 +31% $13.40 59,000 10 Aug 2023 By Trust F1, F2
holding AVDL ADSs 65,700 10 Aug 2023 By Trust F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
F2 These ADSs are held by The Geoffrey Glass Trust of which the reporting person is a co-trustee. The reporting person is the sole beneficiary of the trust.
F3 These ADSs are held by Geoffrey M. Glass Revocable Trust U/T/D August 26, 2020 of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust.